Amid the global uncertainty of COVID-19, Trivitron Healthcare counts for the continuity of services & solutions for COVID-19. announce the launch of a full suite of indigenously developed COVID-19 Testing products. The organisation dedicates this achievement to the PM Narendra Modi’s ‘Local for Vocal’ drive, where he urges Indian citizens and organisations to be self-reliant.
Trivitron Healthcare offers a comprehensive range of ICMR approved COVID-19 solutions including RNA Extraction kits (RNAsure), Viral Transport Media (ViSure), RT-PCR Tests (COVIDsure&COVIDsure Pro), Total Antibody ELISA Test (COVIDscreen Plus) and ELISA IgG (COVID Kavach IgG) testing kits for Covid-19.
Realizing the enormous need of testing kits in the domestic market, to address this, the organization has indigenously designed & developed and had started large scale manufacturing for COVID-19 RT‑PCR test kits, RNA Extraction kits, Viral Transport Media, ELISA Antibody Tests, and will soon be launching Rapid POC Tests as well, for the Indian market. Trivitron is committed to manufacturer cost-effective and globally-accepted high-quality kits, and other COVID-19 solutions.
“We have been focused on making world-class Made-in-India medical technology solutions for domestic and global markets. The current situation of COVID-19 pandemic demanded innovation in developing indigenous and economical testing kits for the Indian market and we have responded to this. We have a complete range of COVID testing portfolio which will enable scaling up of current testing needs of the Indian & International Healthcare Ecosystem.’’ stated, Dr GSK Velu, Chairman and Managing Director at Trivitron Healthcare.
Trivitron’s recent communication to media reads that it has been tracking the alarming spread of COVID-19 since the world media started reporting its devastating impact on China. Trivitron as a torchbearer of the ‘Make in India’ initiative and supporting the country’s leadership’s call for a self-reliant nation, has decided to accelerate and enhance products and countermeasures to combat the spread of COVID‑19 in India, as the healthcare company claims.
The company further informed that it started putting efforts to upscale the indigenously create required solutions before March 2020, without losing time. Within the given constraints and available resources, the operations continued at Trivitron’s state-of-the-art facilities – Trivitron Medical Technology Park, Chennai, and AMTZ, Vishakhapatnam. As a result of this approach, Trivitron is the only Indian organization that is ready with a complete range of indigenously developed technologies which can be utilized for combating COVID-19 along with to fulfiling the low-cost testing needs for the country.
Besides coming up with the indigenously manufactured Comprehensive COVID-19 testing solutions, Trivitron ensures the best suppliers across the world.